NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $10,143,000 | +142.4% | 95,451 | +36.2% | 0.43% | +96.4% |
| Q4 2017 | $4,184,000 | -58.8% | 70,062 | -83.4% | 0.22% | -57.0% |
| Q3 2017 | $10,154,000 | +25.2% | 423,100 | +2.0% | 0.51% | +16.6% |
| Q2 2017 | $8,109,000 | +200.0% | 414,800 | +260.2% | 0.44% | +227.6% |
| Q1 2017 | $2,703,000 | +6.6% | 115,150 | -44.3% | 0.13% | -20.2% |
| Q4 2016 | $2,535,000 | +28.0% | 206,600 | +14.3% | 0.17% | -1.2% |
| Q3 2015 | $1,981,000 | +18.3% | 180,716 | +24.6% | 0.17% | -0.6% |
| Q2 2013 | $1,675,000 | – | 145,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |